Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets

Mostrar otras versiones (1)

Containment of the COVID-19 pandemic requires reducing viral transmission. SARS-CoV-2 infection is initiated by membrane fusion between the viral and host cell membranes, mediated by the viral spike protein. We have designed a dimeric lipopeptide fusion inhibitor that blocks this critical first step...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vries, Rory D., Schmitz, Katharina S., Bovier, Francesca T., Noack, Danny, Haagmans, Bart L., Biswas, Sudipta, Rockx, Barry, Gellman, Samuel H., Alabi, Christopher A., de Swart, Rik L., Moscona, Anne, Porotto, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654853/
https://www.ncbi.nlm.nih.gov/pubmed/33173865
http://dx.doi.org/10.1101/2020.11.04.361154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654853/
https://www.ncbi.nlm.nih.gov/pubmed/33173865
http://dx.doi.org/10.1101/2020.11.04.361154

Ejemplares similares